Biotech Scan

Scan

Biotech Scan

Scan symbols 39
ABBVALNYAMGNBEAMBIIBBMRNBNTXCOGTCRSPDHRDNADXCMEDITEXASGILDIBBILMNINCYIONSIQVISRGKYMRLABULEGNLLYMDTMRNANKTRNTLANVOPTGXRAREREGNRXRXSRPTTMOVEEVVRTXXBI
Watchlists 1
@biotech-scan
raw scan snapshot — prices as of scan date, not live 54 rows · screens, not recommendations ported fromresearch/classic/scans/_archive/2026-04-28-biotech-scan.mdscan slugbiotech-scansource typescan-archive

Sector pullback continues — large pharma weakening (LLY -22.9% from high, ABBV RSI 34.5), gene editing names volatile (CRSP, NTLA, EDIT all -12 to -17% on the week), but BEAM and EXAS still strong-up.

Quick Snapshot

Signal Reading
Overall 🟡 Mixed-to-bearish — pharma cooling, gene editing whipsawing, biotech ETFs flat
Leaders NKTR (+138% 3M), PTGX (+29% 3M, RSI 60), BEAM (+40% 30D), NVO bounce (+17% 30D off death-cross lows)
Laggards NTLA (-18% 7D, RSI 44), CRSP (-13% 7D), MRNA (-13% 7D, RSI 37), DHR (RSI 36, -26% from high)
Key insight LLY breaking down (RSI 38, -23% from high, -14.5% 3M); ISRG strong-down with deathcross still in effect; PTGX is the biotech monster (+462% 3y, +462% alpha)

Price Table

Stock Price RSI vs SMA20 7D% 30D% 3M% 52wkHi Trend Signal
ABBV $197.69 34.5 ↓ -3.9% -3.59% -6.47% -9.57% -19.25% down 🔍 Watch
GILD $129.26 32.4 ↓ -5.6% -4.24% -5.19% -6.85% -17.82% weak-down 🔍 Watch
AMGN $339.57 39.3 -2.4% -0.86% -2.70% -0.30% -13.22% weak-down 🔍 Watch
REGN $746.46 45.2 -1.0% -2.10% -1.38% -0.90% -9.09% weak-down 🔒 Hold
BIIB $183.38 51.3 +1.7% -3.28% -2.23% +4.09% -9.40% weak-down 🔒 Hold
LLY $874.00 37.6 ↓ -5.0% -3.22% -1.42% -14.52% -22.92% down 🔍 Watch
VRTX $440.05 44.1 -1.6% -0.56% -5.59% -2.11% -13.85% weak-down 🔍 Watch
NVO $41.17 60.9 +6.0% +4.46% +16.66% -28.06% -49.45% weak-up 🔍 Research
BNTX $102.06 54.4 +3.6% -7.45% +19.72% -12.60% -17.69% weak-up 🔍 Watch
MRNA $47.14 37.3 ↓ -8.8% -12.65% -2.26% +0.60% -20.84% weak-down 🔍 Watch
ALNY $302.11 39.9 -5.5% +0.59% -4.42% -12.88% -39.04% strong-down 🔍 Watch
BMRN $53.30 39.1 -3.3% -2.23% -2.72% -6.47% -19.58% down 🔍 Watch
INCY $97.74 56.0 +1.9% -0.97% +8.20% -3.30% -12.96% strong-up 🔒 Hold
CRSP $52.06 48.6 -1.6% -12.58% +17.41% -2.42% -33.66% strong-down 🔍 Watch
BEAM $30.56 58.2 +8.4% -6.66% +39.54% +4.34% -16.14% strong-up 🔒 Hold
EDIT $3.06 54.8 +0.5% -17.38% +37.22% +48.54% -32.55% up ⚠️ Speculative
NTLA $13.20 44.4 -6.8% -17.85% +13.30% -5.04% -53.27% weak-down 🔍 Watch
LEGN $23.56 64.5 +12.7% -7.58% +36.11% +32.96% -47.99% weak-up 🔍 Watch
RXRX $3.42 53.9 +6.5% +3.13% +0.88% -29.48% -52.37% strong-down ⚠️ Speculative
ILMN $126.92 47.8 -1.0% -5.71% +5.06% -15.21% -18.40% strong-up 🔍 Watch
DHR $178.98 35.8 ↓ -5.9% -9.10% -2.67% -18.33% -26.29% strong-down 🔍 Watch
TMO $514.23 58.9 +5.8% +1.59% +9.41% -17.22% -20.15% weak-up 🔍 Watch
A $114.87 44.7 -1.9% -6.87% +2.79% -13.61% -28.33% strong-down 🔍 Watch
EXAS $104.91 76.5 ↑ +1.2% +1.13% +1.02% +2.55% -0.07% strong-up ⚠️ Overbought
DXCM $59.32 33.9 ↓ -5.7% -4.06% -4.17% -19.84% -34.07% strong-down 🔍 Watch
SRPT $21.79 56.5 +7.5% -9.72% +30.79% -4.43% -66.37% up ⚠️ Speculative
IONS $71.78 37.2 -4.0% -3.15% -1.02% -14.43% -17.25% weak-down 🔍 Watch
RARE $25.18 68.3 +16.4% +4.91% +15.40% +11.96% -40.57% weak-up 🔍 Watch
PTGX $105.44 59.8 +3.7% +0.06% +8.98% +28.60% -2.23% strong-up 🔒 Hold
DNA $7.85 55.2 +6.6% -10.95% +43.25% -15.68% -55.35% weak-up ⚠️ Speculative
ISRG $466.64 48.5 +0.7% +1.46% +3.06% -8.06% -22.73% strong-down 🔍 Watch
MDT $81.90 32.6 ↓ -4.4% -2.36% -4.48% -18.25% -22.98% strong-down 🔍 Watch
IQV $158.98 36.3 ↓ -6.9% -9.14% -4.32% -32.53% -35.65% strong-down 🔍 Watch
XBI $132.05 61.3 +5.4% -0.34% +6.57% +4.12% -1.16% strong-up 🔒 Hold
IBB $167.81 43.4 -2.3% -3.49% +3.68% -3.62% -6.59% weak-down 🔒 Hold
LABU $177.09 47.6 -4.8% -10.93% +30.41% +1.53% -16.64% strong-up 🔍 Watch
COGT $36.34 49.3 -0.4% -1.21% +2.68% -3.48% -16.90% weak-down 🔍 Watch
KYMR $83.85 47.1 -3.1% -0.47% +5.50% +13.45% -18.59% weak-down 🔍 Watch
NKTR $83.81 53.2 +0.7% -13.69% +28.44% +137.89% -23.11% strong-up 🔒 Hold

Tier Analysis

Tier 1 — Strong Up (Thesis Working)

  • NKTR ($83.81, +138% 3M) — biotech monster, 644% alpha 1y. Riding huge multi-year thesis.
  • PTGX ($105.44, +29% 3M) — strong-up, golden cross, 95% alpha 1y. Near 52wk high.
  • BEAM ($30.56, +40% 30D) — gene editing leader holding momentum, +22.8% above SMA200.
  • EXAS ($104.91, RSI 76.5) — at 52wk highs, overbought but trend intact (+140% 1y).
  • XBI ETF ($132.05) — biotech sector ETF strong-up, +20% above SMA200.

Tier 2 — Quality on Sale (Watch)

  • GILD ($129.26, RSI 32.4) — approaching oversold, weak-down but +28% 1y, alpha intact.
  • AMGN ($339.57, RSI 39) — pulled back -2.7% 30D, holding above SMA200.
  • REGN ($746.46) — only -9% from high, weak-down but +33% 1y.

Tier 3 — Breaking Down (Caution)

  • LLY ($874, -14.5% 3M) — the obesity king losing momentum. -23% from high, RSI 37.6. The big read on GLP-1 thesis.
  • DHR ($178.98, RSI 36, deathcross) — life-sciences tools breakdown, -18% 3M.
  • MDT ($81.90, RSI 32.6, deathcross) — medical devices weakening.
  • DXCM ($59.32, deathcross) — CGM thesis fading, -34% from high.
  • IQV ($158.98, -32.5% 3M) — CRO breakdown, deathcross active.
  • VEEV (in healthcare-scan) — flagged separately, -49% from high, RSI 32.9.

Tier 4 — Speculative / Falling Knives

  • NTLA ($13.20, -53% from high) — gene editing hopeful, big drawdown.
  • EDIT ($3.06) — micro-cap, +37% 30D bounce off lows but no fundamentals.
  • RXRX ($3.42, -52% from high) — AI biotech narrative fading.
  • DNA ($7.85, -55% from high) — Ginkgo bouncing off bottom +43% 30D, deathcross.
  • SRPT ($21.79, -66% from high) — gene therapy collapse.

Tier 5 — Bouncing Off Multi-Year Lows

  • NVO ($41.17) — +16.7% 30D bounce off death-cross lows, but -49% from high. Watch for trend reversal confirmation.
  • BNTX ($102.06, +19.7% 30D) — mRNA recovery attempt.
  • CRSP ($17.4% 30D bounce) — gene editing thawing.

Entry Zones

Stock Price Zone RSI 30D% Setup
GILD $129.26 <$130 32.4 ↓ -5.19% RSI approaching oversold, +145% 5y, alpha 5y +68. Quality at discount.
ABBV $197.69 <$200 34.5 ↓ -6.47% Approaching oversold, but in down trend. Wait for stabilization.
MDT $81.90 <$85 32.6 ↓ -4.48% Deep oversold, but deathcross — wait for trend change.
LLY $874 <$900 37.6 -1.42% The big GLP-1 question. Wait for $850 floor or RSI <30 capitulation.
BIIB $183.38 $180-190 51.3 -2.23% Holding above SMA200, neutral RSI. Watch only.

Action Matrix

Action Stocks Why
🔒 HOLD NKTR, PTGX, BEAM, INCY, REGN, BIIB, XBI, IBB Trends intact, thesis working
📈 ACCUMULATE GILD RSI 32.4, quality pharma at discount
🔍 WATCH LLY, ABBV, AMGN, MRNA, ALNY, BMRN, ILMN, A, IONS, MDT, DXCM, IQV, DHR, ISRG, VRTX Pulling back, need trend confirmation
🔍 RESEARCH NVO, BNTX, CRSP Bouncing from lows — real reversal or dead-cat?
⚠️ AVOID EXAS RSI 76.5 at 52wk high
⚠️ SPECULATIVE EDIT, NTLA, RXRX, DNA, SRPT, LEGN, RARE Down 30-66% from highs, micro-cap risk

What Changed (vs April 10 scan)

  • LLY breaking lower — was -13% 3M, now -14.5% 3M, RSI 47 → 37.6. The GLP-1 narrative continues to deflate.
  • Gene editing whipsaw — CRSP, NTLA, EDIT all bounced 17-37% over 30D but gave back 12-18% in last week.
  • NVO finally bouncing — +16.7% 30D off the -54% low. Still in death cross.
  • NKTR still on fire — +137.9% 3M, holding monster status.
  • MRNA cooling — was strong-up at +54% 3M, now weak-down (-13% 7D, RSI 37).
  • DHR new breakdown — was holding, now -26% from high with RSI 36 and deathcross.
  • GILD slipping into oversold — RSI now 32.4, was 50.0 in April. Approaching buyable level.
  • ISRG continues strong-down — RSI 48.5 but deathcross active, -23% from high (was hot in insider-scan back in Feb).
10 events
DateTypeEvent
Apr 26 ScanBiotech Scan May 29 ScanBiotech Scan Jun 16 ScanBiotech Scan Mar 20 ScanBiotech Scan Mar 26 ScanBiotech Scan Mar 12 ScanBiotech Scan Mar 11 ScanBiotech Scan Mar 10 ScanBiotech Scan Jun 26 ScanBiotech Scan Mar 13 ScanBiotech Scan

No direct external sources are attached to this read.